These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 30697787

  • 1. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
    Lu Q, Zhang XL, Han H, Huang BJ, Ding H, Wang WP.
    J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
    [Abstract] [Full Text] [Related]

  • 2. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z, Liu G, Lu MD, Xie X, Kuang M, Wang W, Xu Z, Lin M, Chen L.
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [Abstract] [Full Text] [Related]

  • 3. Dynamic Contrast-Enhanced Ultrasonography Combined With LR-M Classification Criteria for Differentiating Malignant Liver Nodules at High Risk for Hepatocellular Carcinoma.
    Qiu S, Ding J, Wang Y, Zhou H, Zhao L, Zhao L, Zhou Y, Fu Y, Jing X.
    Ultrasound Med Biol; 2024 Jul; 50(7):1028-1033. PubMed ID: 38632025
    [Abstract] [Full Text] [Related]

  • 4. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
    Yue WW, Wang S, Xu HX, Sun LP, Guo LH, Bo XW, Li XL, Zhao CK, Wang D, Liu BJ.
    Clin Hemorheol Microcirc; 2016 Nov 25; 64(2):177-188. PubMed ID: 27258196
    [Abstract] [Full Text] [Related]

  • 5. Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma.
    Pei XQ, Liu LZ, Xiong YH, Zou RH, Chen MS, Li AH, Cai MY.
    Br J Radiol; 2013 Mar 25; 86(1023):20120536. PubMed ID: 23392189
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, Friedrich-Rust M, Bernatik T.
    Ultraschall Med; 2009 Aug 25; 30(4):376-82. PubMed ID: 19688669
    [Abstract] [Full Text] [Related]

  • 8. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization.
    Pei XQ, Liu LZ, Zheng W, Cai MY, Han F, He JH, Li AH, Chen MS.
    Eur J Radiol; 2012 Mar 25; 81(3):e182-8. PubMed ID: 21349669
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
    Feng Y, Qin XC, Luo Y, Li YZ, Zhou X.
    Ultrasound Med Biol; 2015 Jun 25; 41(6):1553-60. PubMed ID: 25747937
    [Abstract] [Full Text] [Related]

  • 10. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.
    Huang Z, Wu X, Li S, Li K.
    Ultrasound Med Biol; 2020 Jun 25; 46(6):1403-1411. PubMed ID: 32165015
    [Abstract] [Full Text] [Related]

  • 11. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
    Huang JY, Li JW, Ling WW, Li T, Luo Y, Liu JB, Lu Q.
    World J Gastroenterol; 2020 Jul 21; 26(27):3938-3951. PubMed ID: 32774068
    [Abstract] [Full Text] [Related]

  • 12. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma.
    Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, Oikawa T, Sawara K, Takikawa Y.
    World J Gastroenterol; 2019 May 21; 25(19):2365-2372. PubMed ID: 31148907
    [Abstract] [Full Text] [Related]

  • 13. Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound.
    Li H, Lu J, Zhou X, Pan D, Guo D, Ling H, Yang H, He Y, Chen G.
    Ultrasound Med Biol; 2017 Oct 21; 43(10):2469-2476. PubMed ID: 28684184
    [Abstract] [Full Text] [Related]

  • 14. Savitzky-Golay filter based contrast-enhanced ultrasound quantification in hepatic tumors: Methodology and its correlation with tumor angiogenesis.
    Peng S, Ding H, Fu T, Wang B, Wang W, Zhou J.
    Clin Hemorheol Microcirc; 2019 Oct 21; 73(2):271-282. PubMed ID: 30103307
    [Abstract] [Full Text] [Related]

  • 15. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
    Kong WT, Wang WP, Huang BJ, Ding H, Mao F.
    J Gastroenterol Hepatol; 2014 Mar 21; 29(3):576-80. PubMed ID: 24118042
    [Abstract] [Full Text] [Related]

  • 16. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
    Forner A, Vilana R, Bianchi L, Rodríguez-Lope C, Reig M, García-Criado MÁ, Rimola J, Solé M, Ayuso C, Bru C, Bruix J.
    J Hepatol; 2015 Jan 21; 62(1):150-5. PubMed ID: 25173969
    [Abstract] [Full Text] [Related]

  • 17. Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound.
    Zhang P, Chen Y, Liu J, Yang Y, Lv Q, Wang J, Zhang L, Xie M.
    Ultrasound Med Biol; 2018 Apr 21; 44(4):840-852. PubMed ID: 29395676
    [Abstract] [Full Text] [Related]

  • 18. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
    Li F, Han J, Han F, Wang JW, Luo RZ, Li AH, Zhou JH.
    AJR Am J Roentgenol; 2017 Oct 21; 209(4):767-774. PubMed ID: 28777653
    [Abstract] [Full Text] [Related]

  • 19. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
    Li F, Li Q, Liu Y, Han J, Zheng W, Huang Y, Zheng X, Cao L, Zhou JH.
    Eur Radiol; 2020 Jan 21; 30(1):461-470. PubMed ID: 31297632
    [Abstract] [Full Text] [Related]

  • 20. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
    Yang D, Li R, Zhang XH, Tang CL, Ma KS, Guo DY, Yan XC.
    Sci Rep; 2018 Mar 16; 8(1):4713. PubMed ID: 29549368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.